DTIL vs IQV · rev $10.8M vs P/E 23, rev $16.31B
Precision BioSciences Inc (DTIL) versus IQVIA Holdings Inc (IQV) — a side-by-side from cached financials, not a winner call.
Precision BioSciences Inc (DTIL) is a biotechnology company listed on US.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
Latest reported DTIL revenue for 2026-06-30 was $10.8M. Net income was -$51.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. DTIL currently screens at market cap $48.1M.
Latest reported IQV revenue for 2025-12-31 was $16.31B. Net income was $1.36B. Revenue was up 5.9% from 2024-12-31 to 2025-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
DTIL currently screens at market cap $48.1M. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
Not investment advice. Open the DTIL and IQV stock pages for the full models.
Not investment advice.